Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.840
+0.090 (1.89%)
Nov 5, 2024, 4:00 PM EST - Market closed

Elicio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
5280----
Enterprise Value
5372----
Last Close Price
4.618.34----
PE Ratio
--1.20----
PB Ratio
-25.427.04----
P/FCF Ratio
-1.16-2.45----
P/OCF Ratio
-1.16-2.45----
EV/EBITDA Ratio
-0.90-2.04----
EV/EBIT Ratio
-0.89-2.02----
EV/FCF Ratio
-1.02-2.20----
Debt / Equity Ratio
-3.890.610.84-2.880.030.13
Debt / FCF Ratio
-0.18-0.21-0.33-0.48-0.03-0.09
Quick Ratio
0.461.320.900.494.533.90
Current Ratio
0.881.671.560.554.674.15
Return on Equity (ROE)
-353.02%-346.95%-1170.93%-430.76%-136.60%-
Return on Assets (ROA)
-96.80%-89.70%-79.16%-92.36%-68.96%-
Return on Capital (ROIC)
-144.59%-128.82%-123.12%-130.00%-80.83%-
Earnings Yield
-77.95%-43.93%----
FCF Yield
-73.01%-40.89%----
Buyback Yield / Dilution
-896.37%-1500.08%97.93%-42.39%-172.21%-
Total Shareholder Return
-896.37%-1500.08%97.93%-42.39%-172.21%-
Source: S&P Capital IQ. Standard template. Financial Sources.